Maze Therapeutics, Inc. (MAZE) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.59B and a free-cash-flow yield of -9.2%. Over the most recent reported fiscal year, revenue declined 100.0% and free cash flow per share fell 253.5%.